vs

Side-by-side financial comparison of Arteris, Inc. (AIP) and TriSalus Life Sciences, Inc. (TLSI). Click either name above to swap in a different company.

Arteris, Inc. is the larger business by last-quarter revenue ($20.1M vs $13.2M, roughly 1.5× TriSalus Life Sciences, Inc.). Arteris, Inc. runs the higher net margin — -42.2% vs -73.9%, a 31.6% gap on every dollar of revenue. On growth, TriSalus Life Sciences, Inc. posted the faster year-over-year revenue change (59.8% vs 30.0%). Arteris, Inc. produced more free cash flow last quarter ($3.0M vs $-2.5M). Over the past eight quarters, TriSalus Life Sciences, Inc.'s revenue compounded faster (43.0% CAGR vs 24.7%).

Arteris, Inc. is a multinational technology company headquartered in Campbell, California. It develops the network-on-chip (NoC) IP and system-on-chip (SoC) integration automation software that is used to create semiconductor chip and chiplet designs for a variety of devices, particularly in automotive electronics, artificial intelligence, machine learning, enterprise computing, communications, consumer, industrial, and aerospace & defense markets. The company specializes in the development a...

TriSalus Life Sciences, Inc. is a clinical-stage biotechnology company focused on advancing immuno-oncology and interventional oncology solutions. It develops proprietary targeted drug delivery technologies designed to improve treatment efficacy for patients with liver, pancreatic and other hard-to-treat solid tumors, primarily operating in North American markets via partnerships with clinical care and research institutions.

AIP vs TLSI — Head-to-Head

Bigger by revenue
AIP
AIP
1.5× larger
AIP
$20.1M
$13.2M
TLSI
Growing faster (revenue YoY)
TLSI
TLSI
+29.8% gap
TLSI
59.8%
30.0%
AIP
Higher net margin
AIP
AIP
31.6% more per $
AIP
-42.2%
-73.9%
TLSI
More free cash flow
AIP
AIP
$5.6M more FCF
AIP
$3.0M
$-2.5M
TLSI
Faster 2-yr revenue CAGR
TLSI
TLSI
Annualised
TLSI
43.0%
24.7%
AIP

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
AIP
AIP
TLSI
TLSI
Revenue
$20.1M
$13.2M
Net Profit
$-8.5M
$-9.8M
Gross Margin
90.8%
86.7%
Operating Margin
-42.0%
-24.8%
Net Margin
-42.2%
-73.9%
Revenue YoY
30.0%
59.8%
Net Profit YoY
-3.7%
3.5%
EPS (diluted)
$-0.19
$-0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AIP
AIP
TLSI
TLSI
Q4 25
$20.1M
$13.2M
Q3 25
$17.4M
$11.6M
Q2 25
$16.5M
$11.2M
Q1 25
$16.5M
$9.2M
Q4 24
$15.5M
$8.3M
Q3 24
$14.7M
$7.3M
Q2 24
$14.6M
$7.4M
Q1 24
$12.9M
$6.5M
Net Profit
AIP
AIP
TLSI
TLSI
Q4 25
$-8.5M
$-9.8M
Q3 25
$-9.0M
$-10.8M
Q2 25
$-9.1M
$-8.3M
Q1 25
$-8.1M
$-10.4M
Q4 24
$-8.2M
$-10.1M
Q3 24
$-7.7M
$-2.4M
Q2 24
$-8.3M
$-4.3M
Q1 24
$-9.4M
$-13.2M
Gross Margin
AIP
AIP
TLSI
TLSI
Q4 25
90.8%
86.7%
Q3 25
89.9%
83.5%
Q2 25
89.4%
83.9%
Q1 25
90.8%
83.7%
Q4 24
89.8%
85.3%
Q3 24
90.1%
86.3%
Q2 24
90.0%
87.6%
Q1 24
88.7%
85.0%
Operating Margin
AIP
AIP
TLSI
TLSI
Q4 25
-42.0%
-24.8%
Q3 25
-50.1%
-77.9%
Q2 25
-50.0%
-65.4%
Q1 25
-46.6%
-79.9%
Q4 24
-45.9%
-91.8%
Q3 24
-53.8%
-118.9%
Q2 24
-51.1%
-111.0%
Q1 24
-70.5%
-180.8%
Net Margin
AIP
AIP
TLSI
TLSI
Q4 25
-42.2%
-73.9%
Q3 25
-51.6%
-93.5%
Q2 25
-55.3%
-73.9%
Q1 25
-49.1%
-113.2%
Q4 24
-53.0%
-122.4%
Q3 24
-52.2%
-32.6%
Q2 24
-57.2%
-58.8%
Q1 24
-72.6%
-204.5%
EPS (diluted)
AIP
AIP
TLSI
TLSI
Q4 25
$-0.19
$-0.22
Q3 25
$-0.21
$-0.96
Q2 25
$-0.22
$-0.27
Q1 25
$-0.20
$-0.39
Q4 24
$-0.19
$-0.38
Q3 24
$-0.20
$-0.12
Q2 24
$-0.22
$-0.21
Q1 24
$-0.25
$-0.60

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AIP
AIP
TLSI
TLSI
Cash + ST InvestmentsLiquidity on hand
$33.9M
$20.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$-14.6M
$-33.9M
Total Assets
$115.0M
$35.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AIP
AIP
TLSI
TLSI
Q4 25
$33.9M
$20.4M
Q3 25
$39.0M
$22.7M
Q2 25
$38.0M
$26.5M
Q1 25
$42.3M
$13.0M
Q4 24
$43.8M
$8.5M
Q3 24
$48.7M
$11.3M
Q2 24
$45.8M
$16.5M
Q1 24
$44.8M
$4.0M
Stockholders' Equity
AIP
AIP
TLSI
TLSI
Q4 25
$-14.6M
$-33.9M
Q3 25
$-11.4M
$-26.7M
Q2 25
$-7.5M
$-19.4M
Q1 25
$-4.8M
$-34.4M
Q4 24
$-1.2M
$-25.9M
Q3 24
$2.2M
$-20.4M
Q2 24
$5.3M
$-25.3M
Q1 24
$9.5M
$-36.0M
Total Assets
AIP
AIP
TLSI
TLSI
Q4 25
$115.0M
$35.3M
Q3 25
$107.7M
$36.5M
Q2 25
$106.9M
$41.3M
Q1 25
$98.3M
$28.6M
Q4 24
$106.1M
$24.0M
Q3 24
$97.7M
$27.5M
Q2 24
$96.4M
$32.4M
Q1 24
$101.4M
$17.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AIP
AIP
TLSI
TLSI
Operating Cash FlowLast quarter
$3.2M
$-2.5M
Free Cash FlowOCF − Capex
$3.0M
$-2.5M
FCF MarginFCF / Revenue
15.1%
-19.1%
Capex IntensityCapex / Revenue
0.7%
0.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$5.3M
$-19.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AIP
AIP
TLSI
TLSI
Q4 25
$3.2M
$-2.5M
Q3 25
$3.2M
$-3.7M
Q2 25
$-2.5M
$-7.3M
Q1 25
$2.9M
$-4.5M
Q4 24
$-2.6M
$-5.7M
Q3 24
$1.1M
$-10.8M
Q2 24
$311.0K
$-13.4M
Q1 24
$477.0K
$-10.9M
Free Cash Flow
AIP
AIP
TLSI
TLSI
Q4 25
$3.0M
$-2.5M
Q3 25
$2.5M
$-3.9M
Q2 25
$-2.8M
$-7.4M
Q1 25
$2.7M
$-5.3M
Q4 24
$-2.7M
$-5.8M
Q3 24
$1.1M
$-11.0M
Q2 24
$264.0K
$-13.5M
Q1 24
$281.0K
$-10.9M
FCF Margin
AIP
AIP
TLSI
TLSI
Q4 25
15.1%
-19.1%
Q3 25
14.2%
-33.9%
Q2 25
-17.2%
-66.1%
Q1 25
16.2%
-57.3%
Q4 24
-17.3%
-69.7%
Q3 24
7.4%
-149.9%
Q2 24
1.8%
-183.1%
Q1 24
2.2%
-169.3%
Capex Intensity
AIP
AIP
TLSI
TLSI
Q4 25
0.7%
0.3%
Q3 25
4.1%
1.9%
Q2 25
2.2%
0.8%
Q1 25
1.1%
8.2%
Q4 24
0.3%
0.6%
Q3 24
0.2%
2.3%
Q2 24
0.3%
0.8%
Q1 24
1.5%
1.0%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AIP
AIP

License And Maintenance$17.5M87%
Variable Royalties And Other$2.6M13%

TLSI
TLSI

Segment breakdown not available.

Related Comparisons